Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
European Journal of Haematology|December 2, 2025
Enhanced Detection of Multiple Myeloma Cells by Next-Generation Flow Cytometry Following Density Gradient Medium SeparationAisling O'Brien, Vitaliy Mykytiv, Fiona O'HalloranClinical Lymphoma, Myeloma & Leukemia|September 2, 2021
Minimal Residual Disease in Multiple Myeloma: Potential for Blood-Based Methods to Monitor DiseaseAisling O'Brien, Fiona O'Halloran, Vitaliy MykytivClinical Biochemistry|April 29, 2023
Calculated Globulin as a potential screening tool for paraproteinemia to aid in the early diagnosis of Multiple MyelomaAisling O'Brien, Alison Bransfield, Fiona O'Halloran, et al.Frontiers in Veterinary Science|May 14, 2023
Induced pluripotent stem cells in companion animals: how can we move the field forward?Laura Barrachina, Tarlan Eslami Arshaghi, Aisling O'Brien, et al.The Journal of Biological Chemistry|October 6, 2018
ER stress signaling has an activating transcription factor 6α (ATF6)-dependent "off-switch"Franziska Walter, Aisling O'Brien, Caoimhín G Concannon, et al.Journal of Ayub Medical College, Abbottabad : JAMC|November 25, 2024
IMPROVING VTE RISK ASSESSMENT IN HOSPITALISED PATIENTS IN A TERTIARY CARE HOSPITAL IN IRELANDMuhammad Irfan Khan, Aisling O'Brien, Catriona O'Leary, et al.Frontiers in Immunology|July 12, 2021
Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic FunctionAisling O'Brien, Megan Mary Hanlon, Viviana Marzaioli, et al.Osteoarthritis and Cartilage Open|October 10, 2025
Development of an iPSC-based screening platform identifying enhancers of chondrogenesisAisling O'Brien, Maojia Xu, Enda O'Connell, et al.Stem Cell Research & Therapy|October 8, 2025
Generation of equine induced pluripotent stem cells from cells of embryonic, perinatal and adult tissuesLaura Barrachina, Ana Ivanovska, Tarlan Eslami Arshaghi, et al.Stem Cell Research|February 12, 2021
Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.Pageof 2